413 related articles for article (PubMed ID: 18492692)
1. The effect of FK506 on transforming growth factor beta signaling and apoptosis in chronic lymphocytic leukemia B cells.
Romano S; Mallardo M; Chiurazzi F; Bisogni R; D'Angelillo A; Liuzzi R; Compare G; Romano MF
Haematologica; 2008 Jul; 93(7):1039-48. PubMed ID: 18492692
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor impairs the cytochrome C/caspase-3 apoptotic pathway induced by transforming growth factor beta in rat fetal hepatocytes via a phosphoinositide 3-kinase-dependent pathway.
Fabregat I; Herrera B; Fernández M; Alvarez AM; Sánchez A; Roncero C; Ventura JJ; Valverde AM; Benito M
Hepatology; 2000 Sep; 32(3):528-35. PubMed ID: 10960445
[TBL] [Abstract][Full Text] [Related]
3. FK506 can activate transforming growth factor-beta signalling in vascular smooth muscle cells and promote proliferation.
Giordano A; Romano S; Mallardo M; D'Angelillo A; Calì G; Corcione N; Ferraro P; Romano MF
Cardiovasc Res; 2008 Aug; 79(3):519-26. PubMed ID: 18349138
[TBL] [Abstract][Full Text] [Related]
4. FKBP12 is not required for the modulation of transforming growth factor beta receptor I signaling activity in embryonic fibroblasts and thymocytes.
Bassing CH; Shou W; Muir S; Heitman J; Matzuk MM; Wang XF
Cell Growth Differ; 1998 Mar; 9(3):223-8. PubMed ID: 9543388
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta induces cell death in the oligodendroglial cell line OLI-neu.
Schuster N; Bender H; Philippi A; Subramaniam S; Strelau J; Wang Z; Krieglstein K
Glia; 2002 Oct; 40(1):95-108. PubMed ID: 12237847
[TBL] [Abstract][Full Text] [Related]
6. Balance of pro-apoptotic transforming growth factor-beta and anti-apoptotic insulin effects in the control of cell death in the postnatal mouse retina.
Duenker N; Valenciano AI; Franke A; Hernández-Sánchez C; Dressel R; Behrendt M; De Pablo F; Krieglstein K; de la Rosa EJ
Eur J Neurosci; 2005 Jul; 22(1):28-38. PubMed ID: 16029193
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of transforming growth factor beta signaling in MCF-7 cells results in resistance to tumor necrosis factor alpha: a role for Bcl-2.
Tobin SW; Brown MK; Douville K; Payne DC; Eastman A; Arrick BA
Cell Growth Differ; 2001 Feb; 12(2):109-17. PubMed ID: 11243465
[TBL] [Abstract][Full Text] [Related]
8. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
9. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
[TBL] [Abstract][Full Text] [Related]
11. TIEG1 facilitates transforming growth factor-beta-mediated apoptosis in the oligodendroglial cell line OLI-neu.
Bender H; Wang Z; Schuster N; Krieglstein K
J Neurosci Res; 2004 Feb; 75(3):344-52. PubMed ID: 14743447
[TBL] [Abstract][Full Text] [Related]
12. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
Wu CS; Wu PH; Fang AH; Lan CC
Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta induces apoptosis in activated murine T cells through the activation of caspase 1-like protease.
Chung EJ; Choi SH; Shim YH; Bang YJ; Hur KC; Kim CW
Cell Immunol; 2000 Aug; 204(1):46-54. PubMed ID: 11006017
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 regulatory pathway is functional in chronic lymphocytic leukemia.
Goolsby C; Paniagua M; Tallman M; Gartenhaus RB
Cytometry B Clin Cytom; 2005 Jan; 63(1):36-46. PubMed ID: 15624202
[TBL] [Abstract][Full Text] [Related]
15. Role of CD14 expression in the differentiation-apoptosis switch in human monocytic leukemia cells treated with 1alpha,25-dihydroxyvitamin D3 or dexamethasone in the presence of transforming growth factor beta1.
Kanatani Y; Kasukabe T; Okabe-Kado J; Yamamoto-Yamaguchi Y; Nagata N; Motoyoshi K; Honma Y
Cell Growth Differ; 1999 Oct; 10(10):705-12. PubMed ID: 10547074
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor.
Schiemann WP; Rotzer D; Pfeifer WM; Levi E; Rai KR; Knaus P; Kadin ME
Cancer Detect Prev; 2004; 28(1):57-64. PubMed ID: 15041079
[TBL] [Abstract][Full Text] [Related]
17. Effects of RNAi-mediated Smad4 silencing on growth and apoptosis of human rhabdomyosarcoma cells.
Ye L; Zhang H; Zhang L; Yang G; Ke Q; Guo H; Bu H
Int J Oncol; 2006 Nov; 29(5):1149-57. PubMed ID: 17016646
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Fractin in TGF-beta-induced apoptosis in oligodendroglial progenitor cells.
Schulz R; Vogel T; Mashima T; Tsuruo T; Krieglstein K
Glia; 2009 Nov; 57(15):1619-29. PubMed ID: 19330858
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signaling.
Dufour C; Holy X; Marie PJ
Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E794-801. PubMed ID: 18378961
[TBL] [Abstract][Full Text] [Related]
20. ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells.
Noda D; Itoh S; Watanabe Y; Inamitsu M; Dennler S; Itoh F; Koike S; Danielpour D; ten Dijke P; Kato M
Oncogene; 2006 Sep; 25(41):5591-600. PubMed ID: 16636667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
